US3919205A
(en)
|
1972-07-17 |
1975-11-11 |
Squibb & Sons Inc |
Dithiocarbonylthioacetyl cephalosporin derivatives
|
US5166331A
(en)
|
1983-10-10 |
1992-11-24 |
Fidia, S.P.A. |
Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
|
FR2654725B1
(fr)
|
1989-11-23 |
1992-02-14 |
Rhone Poulenc Sante |
Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
US5420297A
(en)
|
1990-10-24 |
1995-05-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptides having substance P antagonistic activity
|
FR2676055B1
(fr)
|
1991-05-03 |
1993-09-03 |
Sanofi Elf |
Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
RO110499B1
(ro)
|
1991-05-31 |
1996-01-30 |
Pfizer |
Derivati de chinuclidina si compozitie farmaceutica continand acesti compusi
|
GB9113219D0
(en)
|
1991-06-19 |
1991-08-07 |
Fujisawa Pharmaceutical Co |
Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
|
JPH06509332A
(ja)
|
1991-07-05 |
1994-10-20 |
メルク シヤープ エンド ドーム リミテツド |
芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用
|
US5552534A
(en)
|
1991-08-22 |
1996-09-03 |
The Trustees Of The University Of Pennsylvania |
Non-Peptide peptidomimetics
|
EP0533280B2
(en)
|
1991-09-20 |
2004-12-01 |
Glaxo Group Limited |
Novel medical use for tachykinin antagonists
|
GB9200535D0
(en)
|
1992-01-10 |
1992-02-26 |
Fujisawa Pharmaceutical Co |
New compound
|
WO1993017032A1
(en)
|
1992-02-24 |
1993-09-02 |
The Trustees Of The University Of Pennsylvania |
Techniques and intermediates for preparing non-peptide peptidomimetics
|
FR2689889B1
(fr)
|
1992-04-10 |
1994-06-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, et leur preparation.
|
TW241258B
(no)
|
1992-04-15 |
1995-02-21 |
Takeda Pharm Industry Co Ltd |
|
US6048859A
(en)
|
1992-06-29 |
2000-04-11 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
US5719147A
(en)
|
1992-06-29 |
1998-02-17 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
IL111002A
(en)
|
1993-09-22 |
1998-09-24 |
Glaxo Group Ltd |
History of piperidine, their preparation and the pharmaceutical preparations containing them
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
IL111730A
(en)
|
1993-11-29 |
1998-12-06 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
|
IL112778A0
(en)
|
1994-03-04 |
1995-05-26 |
Merck & Co Inc |
Substituted heterocycles, their preparation and pharmaceutical compositions containing them
|
FR2718136B1
(fr)
|
1994-03-29 |
1996-06-21 |
Sanofi Sa |
Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
|
DK0783490T3
(da)
|
1994-09-30 |
2002-05-13 |
Novartis Ag |
1-Acyl-4-alifatiske aminopiperidinforbindelser
|
NZ300942A
(en)
|
1995-02-22 |
1998-12-23 |
Novartis Ag |
1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
|
GB9505692D0
(en)
|
1995-03-21 |
1995-05-10 |
Glaxo Group Ltd |
Chemical compounds
|
AU696948B2
(en)
|
1995-03-27 |
1998-09-24 |
Hisamitsu Pharmaceutical Co., Inc. |
Piperidine derivatives
|
DE19519245C2
(de)
|
1995-04-14 |
2003-04-30 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
GB9510600D0
(en)
|
1995-05-25 |
1995-07-19 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives
|
TW382017B
(en)
|
1995-12-27 |
2000-02-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
|
DE19608665A1
(de)
|
1996-03-06 |
1997-09-11 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
US5929094A
(en)
|
1996-10-25 |
1999-07-27 |
Merck & Co., Inc. |
Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
|
AU5239898A
(en)
|
1996-10-25 |
1998-05-15 |
Merck & Co., Inc. |
Phenyl spiroethercycloalkyl tachykinin receptor antagonists
|
GB9625843D0
(en)
|
1996-12-12 |
1997-01-29 |
Merck & Co Inc |
Phenyl spiroethercycloalkyl tachykinn receptor antagonists
|
GB9700597D0
(en)
|
1997-01-14 |
1997-03-05 |
Sandoz Pharma Uk |
Organic compounds
|
JPH10259184A
(ja)
|
1997-03-18 |
1998-09-29 |
Takeda Chem Ind Ltd |
三環性複素環化合物の製造法
|
ZA985765B
(en)
|
1997-07-02 |
1999-08-04 |
Merck & Co Inc |
Polymorphic form of a tachykinin receptor antagonist.
|
TR200000287T2
(tr)
|
1997-08-06 |
2000-07-21 |
Eli Lilly And Company |
Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
|
TW426667B
(en)
|
1997-11-19 |
2001-03-21 |
Pfizer |
Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
|
GB9905010D0
(en)
|
1999-03-04 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6291465B1
(en)
|
1999-03-09 |
2001-09-18 |
Hoffmann-La Roche Inc. |
Biphenyl derivatives
|
CO5150225A1
(es)
|
1999-03-19 |
2002-04-29 |
Merck Sharp & Dohme |
Derivados del tetrahidropirano y su uso como agentes terapeuticos
|
GB9907571D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Compounds
|
ATE290034T1
(de)
|
1999-05-10 |
2005-03-15 |
Diolen Ind Fibers Gmbh |
Fadenbildende polyester und copolyester und verfahren zu deren herstellung
|
JP3229294B2
(ja)
|
1999-06-04 |
2001-11-19 |
キヤノン販売株式会社 |
被成膜面の改質方法及び半導体装置の製造方法
|
WO2001025233A1
(fr)
|
1999-10-07 |
2001-04-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Derives de piperidine
|
GB9923748D0
(en)
|
1999-10-07 |
1999-12-08 |
Glaxo Group Ltd |
Chemical compounds
|
DE60114597T2
(de)
|
2000-04-06 |
2006-07-20 |
Astrazeneca Ab |
Naphthamid-neurokinin antagonisten zur verwendung als medikamente
|
ES2307605T3
(es)
|
2000-04-06 |
2008-12-01 |
Astrazeneca Ab |
Nuevos antagonistas de neuroquininas para su uso como medicamentos.
|
GB0012240D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
CN1327997A
(zh)
|
2000-06-12 |
2001-12-26 |
上海博德基因开发有限公司 |
一种新的多肽——Ras GTP酶激活蛋白9.57和编码这种多肽的多核苷酸
|
DE10036818A1
(de)
|
2000-07-28 |
2002-02-07 |
Solvay Pharm Gmbh |
Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
|
PE20020444A1
(es)
|
2000-09-22 |
2002-06-14 |
Merck & Co Inc |
Antagonistas de receptores de taquiquinina zwitterionica
|
SE0003476D0
(sv)
|
2000-09-28 |
2000-09-28 |
Astrazeneca Ab |
Compounds
|
GB0025354D0
(en)
|
2000-10-17 |
2000-11-29 |
Glaxo Group Ltd |
Chemical compounds
|
US6642226B2
(en)
|
2001-02-06 |
2003-11-04 |
Hoffman-La Roche Inc. |
Substituted phenyl-piperidine methanone compounds
|
GB0108595D0
(en)
|
2001-04-05 |
2001-05-23 |
Glaxo Group Ltd |
Chemical compounds
|
GB0114867D0
(en)
|
2001-06-18 |
2001-08-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0119797D0
(en)
|
2001-08-14 |
2001-10-03 |
Glaxo Group Ltd |
Chemical compounds
|
EP1295599A1
(en)
|
2001-09-21 |
2003-03-26 |
Boehringer Ingelheim International GmbH |
Method for the treatment of prevention of atopic dermatitis
|
PE20030762A1
(es)
|
2001-12-18 |
2003-09-05 |
Schering Corp |
Compuestos heterociclicos como antagonistas nk1
|
KR100887471B1
(ko)
|
2002-01-18 |
2009-03-10 |
교린 세이야꾸 가부시키 가이샤 |
축합 바이사이클릭 피리미딘 유도체
|
GB0203020D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
WO2003066589A1
(en)
|
2002-02-08 |
2003-08-14 |
Glaxo Group Limited |
Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
|
GB0203022D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
JP2004002334A
(ja)
|
2002-03-25 |
2004-01-08 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
AR039329A1
(es)
|
2002-04-26 |
2005-02-16 |
Lilly Co Eli |
Derivados de triazol, antagonistas de receptor de taquicinina
|
GB0215392D0
(en)
|
2002-07-03 |
2002-08-14 |
Glaxo Group Ltd |
Chemical compounds
|
JP2005535650A
(ja)
|
2002-07-03 |
2005-11-24 |
グラクソ グループ リミテッド |
タキキニンアンタゴニストおよびセロトニン再取り込み阻害剤としての置換4−フェニル−ピペリジン−アミド
|
GB0217068D0
(en)
|
2002-07-23 |
2002-08-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0220953D0
(en)
|
2002-09-10 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
GB0310724D0
(en)
|
2003-05-09 |
2003-06-11 |
Glaxo Group Ltd |
Chemical compounds
|
JPWO2005019225A1
(ja)
|
2003-08-21 |
2007-11-01 |
杏林製薬株式会社 |
Nk1受容体拮抗作用を有する化合物の製造方法及びその製造中間体
|
TWI341198B
(en)
|
2004-01-27 |
2011-05-01 |
Merck Sharp & Dohme |
Hydroisoindoline tachykinin receptor antagonists
|
US8108430B2
(en)
|
2004-04-30 |
2012-01-31 |
Microsoft Corporation |
Carousel control for metadata navigation and assignment
|
GB0412865D0
(en)
|
2004-06-09 |
2004-07-14 |
Glaxo Group Ltd |
Chemical compounds
|
AU2005311951A1
(en)
|
2004-12-03 |
2006-06-08 |
Merck & Co., Inc. |
Quinoline tachykinin receptor antagonists
|
EP1819677A4
(en)
|
2004-12-03 |
2009-03-11 |
Merck & Co Inc |
8-phenyl-5,6,7,8-hydroquinolin tachykinin-ANTAGONISTS
|
US7354922B2
(en)
|
2004-12-14 |
2008-04-08 |
Schering Corporation |
Bridged ring NK1 antagonists
|
EP1827420A4
(en)
|
2004-12-14 |
2009-03-04 |
Merck & Co Inc |
OCTAHYDROPYRANO [3,4-c] pyrrole tachykinin receptor Antagonist
|
CA2603030C
(en)
|
2005-03-31 |
2013-11-19 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Benzyloxypropylamine derivative
|
EP1965794A4
(en)
|
2005-12-22 |
2009-10-21 |
Merck & Co Inc |
OCTAHYDROPYRANO [3,4-c] pyrrole tachykinin receptor Antagonist
|
WO2007074491A1
(en)
|
2005-12-28 |
2007-07-05 |
Universita Degli Studi Di Siena |
HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS
|
JP2007277231A
(ja)
|
2006-03-16 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
US20090286777A1
(en)
|
2006-05-15 |
2009-11-19 |
Jianming Bao |
5,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor Antagonists
|
US20100099651A1
(en)
|
2006-10-26 |
2010-04-22 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
JP2008239618A
(ja)
|
2007-02-28 |
2008-10-09 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
JP2010530874A
(ja)
|
2007-06-22 |
2010-09-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
6,5−ピロロピペリジンタキキニン受容体アンタゴニスト
|
KR101630884B1
(ko)
*
|
2008-02-26 |
2016-06-15 |
산도즈 아게 |
모르폴린 유도체의 제조
|
US20100098772A1
(en)
|
2008-10-21 |
2010-04-22 |
Allergan, Inc. |
Drug delivery systems and methods for treating neovascularization
|
CN107050455B
(zh)
*
|
2009-11-18 |
2020-09-29 |
赫尔森保健股份公司 |
用于治疗中枢介导的恶心及呕吐的组合物及方法
|
KR102166277B1
(ko)
|
2013-04-12 |
2020-10-15 |
삼성전자주식회사 |
무선 통신 네트워크를 이용한 운전 지원 방법 및 장치와 그 시스템
|
US11461843B2
(en)
|
2019-05-23 |
2022-10-04 |
Capital One Services, Llc |
Multi-lender platform that securely stores proprietary information for pre-qualifying an applicant
|